These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4403108)

  • 1. Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons.
    Fuxe K; Holmstedt B; Jonsson G
    Eur J Pharmacol; 1972 Jul; 19(1):25-34. PubMed ID: 4403108
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of psychotomimetic glycolate esters on central monoamine neurons.
    Andén NE; Corrodi H; Fuxe K
    Eur J Pharmacol; 1972 Jan; 17(1):97-102. PubMed ID: 4401437
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of serotonin biosynthesis by 6-halotryptophans in vivo.
    Peters DA
    Biochem Pharmacol; 1971 Jul; 20(7):1413-20. PubMed ID: 5163081
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemically induced degeneration of indoleamine-containing nerve terminals in rat brain.
    Baumgarten HG; Lachenmayer L
    Brain Res; 1972 Mar; 38(1):228-32. PubMed ID: 5016002
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of 5,6-dihydroxytryptamine on monoaminergic neurones in the central nervous system of the rat.
    Baumgarten HG; Evetts KD; Holman RB; Iversen LL; Vogt M; Wilson G
    J Neurochem; 1972 Jun; 19(6):1587-97. PubMed ID: 4402486
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurotoxicity of hydroxylated tryptamines: structure-activity relationships. 1. Long-term effects on monoamine content and fluorescence morphology of central monoamine neurons.
    Baumgarten HG; Björklund A; Nobin A; Rosengren E; Schlossberger HG
    Acta Physiol Scand Suppl; 1975; 429():5-27. PubMed ID: 1064287
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor.
    Corrodi H; Fuxe K; Hamberger B; Ljungdahl A
    Eur J Pharmacol; 1970 Oct; 12(2):145-55. PubMed ID: 5472868
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain.
    Uretsky NJ; Iversen LL
    J Neurochem; 1970 Feb; 17(2):269-78. PubMed ID: 5494056
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between brain monoamine levels and Sidman avoidance behavior in rats treated with tyrosine and tryptophan hydroxylase inhibitors.
    Tanaka C; Yo YJ; Takaori S
    Brain Res; 1972 Oct; 45(1):153-64. PubMed ID: 4403884
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of peripherally administered 6-hydroxydopamine on rat brain monoamine turnover.
    Clark WG; Corrodi H; Masuoka DT
    Eur J Pharmacol; 1971 Jun; 15(1):41-4. PubMed ID: 5161339
    [No Abstract]   [Full Text] [Related]  

  • 11. Uptake of exogenous catecholamines by monoamine-containing neurons of the central nervous system: uptake of catecholamines by arcuato-infundibular neurons.
    Lichtensteiger W; Langemann H
    J Pharmacol Exp Ther; 1966 Mar; 151(3):400-8. PubMed ID: 5938477
    [No Abstract]   [Full Text] [Related]  

  • 12. Fusaric (5-butylpicolinic) acid, an inhibitor of dopamine beta-hydroxylase, affects serotonin and noradrenaline.
    Hidaka H
    Nature; 1971 May; 231(5297):54-5. PubMed ID: 4930475
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of prolonged lithium administration on cerebral monoamine neurons in the rat.
    Corrodi H; Fuxe K; Schou M
    Life Sci; 1969 Jun; 8(11):643-51. PubMed ID: 5799284
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain.
    Waldmeier PC; Maître L
    Psychopharmacology (Berl); 1977 Apr; 52(2):137-44. PubMed ID: 407597
    [No Abstract]   [Full Text] [Related]  

  • 15. A possible role played by central monoamine neurones in thermo-regulation.
    Corrodi H; Fuxe K; Hökfelt T
    Acta Physiol Scand; 1967; 71(2):224-32. PubMed ID: 5584531
    [No Abstract]   [Full Text] [Related]  

  • 16. Putative neurotransmitters in the brain: selective neuronal uptake, subcellular localization, and interactions with centrally acting drugs.
    Snyder SH
    Biol Psychiatry; 1970 Oct; 2(4):367-89. PubMed ID: 4320227
    [No Abstract]   [Full Text] [Related]  

  • 17. Biogenic amines in the developing brain.
    Eiduson S
    UCLA Forum Med Sci; 1971; 14():391-418. PubMed ID: 4399509
    [No Abstract]   [Full Text] [Related]  

  • 18. The subcellular distribution of some monoamines following their intraventricular injection into the rat.
    Boulton AA; Baker GB
    Can J Biochem; 1974 Apr; 52(4):288-93. PubMed ID: 4598454
    [No Abstract]   [Full Text] [Related]  

  • 19. Hallucinogenic phenylethylamines: interactions with serotonin turnover and receptors.
    Andén NE; Corrodi H; Fuxe K; Meek JL
    Eur J Pharmacol; 1974 Feb; 25(2):176-84. PubMed ID: 4435021
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.
    Corrodi H; Fuxe K; Hökfelt T; Lidbrink P; Ungerstedt U
    J Pharm Pharmacol; 1973 May; 25(5):409-12. PubMed ID: 4146398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.